The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals
Open accessAbstract
BACKGROUND: The isolation of human monoclonal antibodies (mAbs) that neutralize a broad spectrum of primary HIV-1 isolates and the characterization of the human neutralizing antibody B cell response to HIV-1 infection are important goals that are central to the design of an effective antibody-based vaccine. METHODS AND FINDINGS: We immortalized IgG(+) memory B cells from individuals infected with diverse clades of HIV-1 and selected on the basis of plasma neutralization profiles that were cross-clade and relatively potent. Culture supernatants were screened using various recombinant forms of the envelope glycoproteins (Env) in multiple parallel assays. We isolated 58 mAbs that were mapped to different Env surfaces, most of which showed neutralizing activity. One mAb in particular (HJ16) specific for a novel epitope proximal to the CD4 binding site on gp120 selectively neutralized a multi-clade panel of Tier-2 HIV-1 pseudoviruses, and demonstrated reactivity that was comparable in breadth, but distinct in neutralization specificity, to that of the other CD4 binding site-specific neutralizing mAb b12. A second mAb (HGN194) bound a conserved epitope in the V3 crown and neutralized all Tier-1 and a proportion of Tier-2 pseudoviruses tested, irrespective of clade. A third mAb (HK20) with broad neutralizing activity, particularly as a Fab fragment, recognized a highly conserved epitope in the HR-1 region of gp41, but showed striking assay-dependent selectivity in its activity. CONCLUSIONS: This study reveals that by using appropriate screening methods, a large proportion of memory B cells can be isolated that produce mAbs with HIV-1 neutralizing activity. Three of these mAbs show unusual breadth of neutralization and therefore add to the current panel of HIV-1 neutralizing antibodies with potential for passive protection and template-based vaccine design.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibody neutralization and escape by HIV-1
Wei, X., Decker, J. M., Wang, S., Hui, H., Kappes, J. C., Wu, X., Salazar-Gonzalez, J. F., Salazar, M. G., Kilby, J. M., Saag, M. S., et al. (2003) · Nature · doi:10.1038/nature01470 · Cited by 2,421
Core Structure of gp41 from the HIV Envelope Glycoprotein
Chan, D. C., Fass, D., Berger, J. M., & Kim, P. S. (1997) · Cell · doi:10.1016/s0092-8674(00)80205-6 · Cited by 1,959
Keele, B. F., Giorgi, E. E., Salazar-Gonzalez, J. F., Decker, J. M., Pham, K. T., Salazar, M. G., Sun, C., Grayson, T., Wang, S., Li, H., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802203105 · Cited by 1,912
Self-citationBroad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
Walker, L. M., Phogat, S. K., Chan-Hui, P.-Y., Wagner, D., Phung, P., Goss, J. L., Wrin, T., Simek, M. D., Fling, S., Mitcham, J. L., et al. (2009) · Science · doi:10.1126/science.1178746 · Cited by 1,723
Atomic structure of the ectodomain from HIV-1 gp41
Weissenhorn, W., Dessen, A., Harrison, S. C., Skehel, J. J., & Wiley, D. C. (1997) · Nature · doi:10.1038/387426a0 · Cited by 1,622
Self-citationMascola, J. R., Stiegler, G., VanCott, T. C., Katinger, H., Carpenter, C. B., Hanson, C. E., Beary, H., Hayes, D., Frankel, S. S., Birx, D. L., et al. (2000) · Nature Medicine · doi:10.1038/72318 · Cited by 1,250
Rapid evolution of the neutralizing antibody response to HIV type 1 infection
Richman, D. D., Wrin, T., Little, S. J., & Petropoulos, C. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630530100 · Cited by 1,200
Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody
Burton, D. R., Pyati, J., Koduri, R., Sharp, S. J., Thornton, G. B., Parren, P. W. H. I., Sawyer, L. S. W., Hendry, R. M., Dunlop, N., Nara, P. L., et al. (1994) · Science · doi:10.1126/science.7973652 · Cited by 1,100
Li, M., Gao, F., Mascola, J. R., Stamatatos, L., Polonis, V. R., Koutsoukos, M., Voss, G., Goepfert, P., Gilbert, P., Greene, K. M., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.16.10108-10125.2005 · Cited by 1,070
Self-citationShankarappa, R., Margolick, J. B., Gange, S. J., Rodrigo, A. G., Upchurch, D., Farzadegan, H., Gupta, P., Rinaldo, C. R., Learn, G. H., He, X., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.12.10489-10502.1999 · Cited by 926 · cited 1×
“Env is the most variable HIV-1 gene, with up to 35% sequence diversity among clades, 20% diversity within clades, and 10% diversity in a single infected individual [15,16,17].”
BackgroundFc receptor but not complement binding is important in antibody protection against HIV
Hessell, A. J., Hangartner, L., Hunter, M., Havenith, C. E. G., Beurskens, F. J., Bakker, J. M., Lanigan, C. M. S., Landucci, G., Forthal, D. N., Parren, P. W. H. I., et al. (2007) · Nature · doi:10.1038/nature06106 · Cited by 901
Moir, S., Ho, J., Malaspina, A., Wang, W., DiPoto, A. C., O'Shea, M. A., Roby, G., Kottilil, S., Arthos, J., Proschan, M. A., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072683 · Cited by 901
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
Scheid, J. F., Mouquet, H., Feldhahn, N., Seaman, M. S., Velinzon, K., Pietzsch, J., Ott, R. G., Anthony, R. M., Zebroski, H., Hurley, A., et al. (2009) · Nature · doi:10.1038/nature07930 · Cited by 867
Self-citationBaba, T. W., Liska, V., Hofmann-Lehmann, R., Vlasak, J., Xu, W., Ayehunie, S., Cavacini, L. A., Posner, M. R., Katinger, H., Stiegler, G., et al. (2000) · Nature Medicine · doi:10.1038/72309 · Cited by 849
Zwick, M. B., Labrijn, A. F., Wang, M., Spenlehauer, C., Saphire, E. O., Binley, J. M., Moore, J. P., Stiegler, G., Katinger, H., Burton, D. R., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.10892-10905.2001 · Cited by 797
Mascola, J. R., Lewis, M. G., Stiegler, G., Harris, D., VanCott, T. C., Hayes, D., Louder, M. K., Brown, C. R., Sapan, C. V., Frankel, S. S., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.4009-4018.1999 · Cited by 783
Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition
Calarese, D. A., Scanlan, C. N., Zwick, M. B., Deechongkit, S., Mimura, Y., Kunert, R., Zhu, P., Wormald, M. R., Stanfield, R. L., Roux, K. H., et al. (2003) · Science · doi:10.1126/science.1083182 · Cited by 781
HIV vaccine design and the neutralizing antibody problem
Burton, D. R., Desrosiers, R. C., Doms, R. W., Koff, W. C., Kwong, P. D., Moore, J. P., Nabel, G. J., Sodroski, J., Wilson, I. A., & Wyatt, R. T. (2004) · Nature Immunology · doi:10.1038/ni0304-233 · Cited by 765
Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies
Haynes, B. F., Fleming, J., St. Clair, E. W., Katinger, H., Stiegler, G., Kunert, R., Robinson, J., Scearce, R. M., Plonk, K., Staats, H. F., et al. (2005) · Science · doi:10.1126/science.1111781 · Cited by 744
Structure of a V3-Containing HIV-1 gp120 Core
Huang, C.-C., Tang, M., Zhang, M.-Y., Majeed, S., Montabana, E., Stanfield, R. L., Dimitrov, D. S., Korber, B., Sodroski, J., Wilson, I. A., et al. (2005) · Science · doi:10.1126/science.1118398 · Cited by 731
Binley, J. M., Wrin, T., Korber, B., Zwick, M. B., Wang, M., Chappey, C., Stiegler, G., Kunert, R., Zolla-Pazner, S., Katinger, H., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.13232-13252.2004 · Cited by 705
B cells in HIV infection and disease
Moir, S., & Fauci, A. S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2524 · Cited by 702
Traggiai, E., Becker, S., Subbarao, K., Kolesnikova, L., Uematsu, Y., Gismondo, M. R., Murphy, B. R., Rappuoli, R., & Lanzavecchia, A. (2004) · Nature Medicine · doi:10.1038/nm1080 · Cited by 697 · cited 5×
“Some of the neutralization data for the reference mAbs b12, 2G12, 2F5 and 4E10 are taken from previous analyses [41,42] carried out under identical standardized conditions to those used for the new mAbs reported here.”
BackgroundMethodInfluentialSelf-citationHIV Enters Cells via Endocytosis and Dynamin-Dependent Fusion with Endosomes
Miyauchi, K., Kim, Y., Latinovic, O., Morozov, V., & Melikyan, G. B. (2009) · Cell · doi:10.1016/j.cell.2009.02.046 · Cited by 681
Burton, D. R., Barbas, C. F., Persson, M. A., Koenig, S., Chanock, R. M., & Lerner, R. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10134 · Cited by 663
Parren, P. W. H. I., Marx, P. A., Hessell, A. J., Luckay, A., Harouse, J., Cheng-Mayer, C., Moore, J. P., & Burton, D. R. (2001) · Journal of Virology · doi:10.1128/jvi.75.17.8340-8347.2001 · Cited by 662
Antibodies, viruses and vaccines
Burton, D. R. (2002) · Nature Reviews Immunology · doi:10.1038/nri891 · Cited by 637
Evaluating Neutralizing Antibodies Against HIV, SIV, and SHIV in Luciferase Reporter Gene Assays
Montefiori, D. C. (2004) · Current Protocols in Immunology · doi:10.1002/0471142735.im1211s64 · Cited by 580
Self-citationSanders, R. W., Venturi, M., Schiffner, L., Kalyanaraman, R., Katinger, H., Lloyd, K. O., Kwong, P. D., & Moore, J. P. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.7293-7305.2002 · Cited by 553
BUCHACHER, A., PREDL, R., STRUTZENBERGER, K., STEINFELLNER, W., TRKOLA, A., PURTSCHER, M., GRUBER, G., TAUER, C., STEINDL, F., JUNGBAUER, A., et al. (1994) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1994.10.359 · Cited by 529
Sather, D. N., Armann, J., Ching, L. K., Mavrantoni, A., Sellhorn, G., Caldwell, Z., Yu, X., Wood, B., Self, S., Kalams, S., et al. (2009) · Journal of Virology · doi:10.1128/jvi.02036-08 · Cited by 528
Stiegler, G., Kunert, R., Purtscher, M., Wolbank, S., Voglauer, R., Steindl, F., & Katinger, H. (2001) · AIDS Research and Human Retroviruses · doi:10.1089/08892220152741450 · Cited by 517
Trkola, A., Kuster, H., Rusert, P., Joos, B., Fischer, M., Leemann, C., Manrique, A., Huber, M., Rehr, M., Oxenius, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1244 · Cited by 502
Roben, P., Moore, J. P., Thali, M., Sodroski, J., Barbas, C. F., & Burton, D. R. (1994) · Journal of Virology · doi:10.1128/jvi.68.8.4821-4828.1994 · Cited by 455
Reeves, J. D., Gallo, S. A., Ahmad, N., Miamidian, J. L., Harvey, P. E., Sharron, M., Pöhlmann, S., Sfakianos, J. N., Derdeyn, C. A., Blumenthal, R., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252469399 · Cited by 404
Protein Design of an HIV-1 Entry Inhibitor
Root, M. J., Kay, M. S., & Kim, P. S. (2001) · Science · doi:10.1126/science.1057453 · Cited by 391
Broad HIV-1 neutralization mediated by CD4-binding site antibodies
Li, Y., Migueles, S. A., Welcher, B., Svehla, K., Phogat, A., Louder, M. K., Wu, X., Shaw, G. M., Connors, M., Wyatt, R. T., et al. (2007) · Nature Medicine · doi:10.1038/nm1624 · Cited by 383
Buonaguro, L., Tornesello, M. L., & Buonaguro, F. M. (2007) · Journal of Virology · doi:10.1128/jvi.00872-07 · Cited by 359
Li, M., Salazar-Gonzalez, J. F., Derdeyn, C. A., Morris, L., Williamson, C., Robinson, J. E., Decker, J. M., Li, Y., Salazar, M. G., Polonis, V. R., et al. (2006) · Journal of Virology · doi:10.1128/jvi.01730-06 · Cited by 359
Self-citationLabrijn, A. F., Poignard, P., Raja, A., Zwick, M. B., Delgado, K., Franti, M., Binley, J., Vivona, V., Grundner, C., Huang, C.-C., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.19.10557-10565.2003 · Cited by 357
Binley, J. M., Lybarger, E. A., Crooks, E. T., Seaman, M. S., Gray, E., Davis, K. L., Decker, J. M., Wycuff, D., Harris, L., Hawkins, N., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01762-08 · Cited by 355
Self-citationTimmerman, P., Beld, J., Puijk, W. C., & Meloen, R. H. (2005) · ChemBioChem · doi:10.1002/cbic.200400374 · Cited by 295
Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12
Calarese, D. A., Lee, H.-K., Huang, C.-Y., Best, M. D., Astronomo, R. D., Stanfield, R. L., Katinger, H., Burton, D. R., Wong, C.-H., & Wilson, I. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505763102 · Cited by 294
Zwick, M. B., Jensen, R., Church, S., Wang, M., Stiegler, G., Kunert, R., Katinger, H., & Burton, D. R. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.1252-1261.2005 · Cited by 278
Li, Y., Svehla, K., Louder, M. K., Wycuff, D., Phogat, S., Tang, M., Migueles, S. A., Wu, X., Phogat, A., Shaw, G. M., et al. (2009) · Journal of Virology · doi:10.1128/jvi.01992-08 · Cited by 259
HIV infection does not require endocytosis of its receptor, CD4
Maddon, P. J., McDougal, J. S., Clapham, P. R., Dalgleish, A. G., Jamal, S., Weiss, R. A., & Axel, R. (1988) · Cell · doi:10.1016/s0092-8674(88)91241-x · Cited by 231
Self-citationConley, A. J., Gorny, M. K., Kessler, J. A., Boots, L. J., Ossorio-Castro, M., Koenig, S., Lineberger, D. W., Emini, E. A., Williams, C., & Zolla-Pazner, S. (1994) · Journal of Virology · doi:10.1128/jvi.68.11.6994-7000.1994 · Cited by 211
Enhanced: The Need for a Global HIV Vaccine Enterprise
Klausner, R. D., Fauci, A. S., Corey, L., Nabel, G. J., Gayle, H., Berkley, S., Haynes, B. F., Baltimore, D., Collins, C., Douglas, R. G., et al. (2003) · Science · doi:10.1126/science.1086916 · Cited by 197
Gorny, M. K., Williams, C., Volsky, B., Revesz, K., Cohen, S., Polonis, V. R., Honnen, W. J., Kayman, S. C., Krachmarov, C., Pinter, A., et al. (2002) · Journal of Virology · doi:10.1128/jvi.76.18.9035-9045.2002 · Cited by 177
Parker, C. E., Deterding, L. J., Hager-Braun, C., Binley, J. M., Schülke, N., Katinger, H., Moore, J. P., & Tomer, K. B. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.10906-10911.2001 · Cited by 159
International Network for Comparison of HIV Neutralization Assays: The NeutNet Report II
Heyndríckx, L., Heath, A., Sheik-Khalil, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036438 · Cited by 137
International Network for Comparison of HIV Neutralization Assays: The NeutNet Report
Fenyõ, É. M., Heath, A., Dispinseri, S., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004505 · Cited by 119
In Vivo and In Vitro Escape from Neutralizing Antibodies 2G12, 2F5, and 4E10
Manrique, A., Rusert, P., Joos, B., Fischer, M., Kuster, H., Leemann, C., Niederöst, B., Weber, R. K., Stiegler, G. M., Katinger, H. W. D., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00598-07 · Cited by 108
Association of Chemokine-mediated Block to HIV Entry with Coreceptor Internalization
Brandt, S. M., Mariani, R., Holland, A. U., Hope, T. J., & Landau, N. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108232200 · Cited by 89
Lusso, P., Earl, P. L., Sironi, F. M., Santoro, F., Ripamonti, C., Scarlatti, G., Longhi, R., Berger, E. A., & Burastero, S. E. (2005) · Journal of Virology · doi:10.1128/jvi.79.11.6957-6968.2005 · Cited by 86
Zhang, M.-Y., Xiao, X., Sidorov, I. A., Choudhry, V., Cham, F., Zhang, P. F., Bouma, P., Zwick, M. B., Choudhary, A., Montefiori, D. C., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.17.9233-9242.2004 · Cited by 83
Self-citationPantophlet, R. A., Aguilar-Sino, R. O., Wrin, T., Cavacini, L. A., & Burton, D. R. (2007) · Virology · doi:10.1016/j.virol.2007.03.007 · Cited by 68
Increased efficacy of HIV-1 neutralization by antibodies at low CCR5 surface concentration
Choudhry, V., Zhang, M.-Y., Harris, I., Sidorov, I. A., Vu, B. K., Dimitrov, A. S., FOUTS, T. R., & Dimitrov, D. S. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.07.163 · Cited by 59
Langedijk, J. P. M., Meloen, R. H., Taylor, G., Furze, J. M., & van Oirschot, J. T. (1997) · Journal of Virology · doi:10.1128/jvi.71.5.4055-4061.1997 · Cited by 56
Self-citationHaynes, B. F., Saag, M. S., Sun, C., Busch, M. P., Pham, K. T., Ping, L.-H., Salazar-Gonzalez, J. F., Goepfert, P. A., Wei, X., Wang, S., et al. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/nta4-xh14 · Cited by 51
Self-citationRobertson, M. J., Williams, B. T., Christopherson, K. W., Brahmi, Z., & Hromas, R. (2000) · Cellular Immunology · doi:10.1006/cimm.1999.1601 · Cited by 50
HIV sensitivity to neutralization is determined by target and virus producer cell properties
Mann, A. M., Rusert, P., Berlinger, L., Kuster, H., Günthard, H. F., & Trkola, A. (2009) · AIDS · doi:10.1097/qad.0b013e32832e9408 · Cited by 47
Wu, X., Sambor, A., Nason, M., Yang, Z., Wu, L., Zolla‐Pazner, S., Nabel, G. J., & Mascola, J. R. (2008) · Virology · doi:10.1016/j.virol.2008.07.007 · Cited by 36
Larcher, C., Bröker, M., Huemer, H. P., Soelder, B., Schulz, T. F., Hofbauer, J. M., Wächter, H., & Dierich, M. P. (1990) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1990.tb03507.x · Cited by 3
Cited by
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Wu, X., Yang, Z.-Y., Li, Y., Hogerkorp, C.-M., Schief, W. R., Seaman, M. S., Zhou, T., Schmidt, S. D., Wu, L., Xu, L., et al. (2010) · Science · doi:10.1126/science.1187659 · Cited by 1,730
Self-citationStructural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
Zhou, T., Georgiev, I., Wu, X., Yang, Z.-Y., Dai, K., Finzi, A., Do Kwon, Y., Scheid, J. F., Shi, W., Xu, L., et al. (2010) · Science · doi:10.1126/science.1192819 · Cited by 1,130
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
Liao, H.-X., Lynch, R., Zhou, T., Gao, F., Alam, S. M., Boyd, S. D., Fire, A. Z., Roskin, K. M., Schramm, C. A., Zhang, Z., et al. (2013) · Nature · doi:10.1038/nature12053 · Cited by 988
Self-citationFocused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing
Wu, X., Zhou, T., Zhu, J., Zhang, B., Georgiev, I., Wang, C., Chen, X., Longo, N. S., Louder, M., McKee, K., et al. (2011) · Science · doi:10.1126/science.1207532 · Cited by 784
Complex-type N -glycan recognition by potent broadly neutralizing HIV antibodies
Mouquet, H., Scharf, L., Euler, Z., Liu, Y., Eden, C., Scheid, J. F., Halper-Stromberg, A., Gnanapragasam, P. N. P., Spencer, D. I. R., Seaman, M. S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217207109 · Cited by 550
Self-citation
Metadata
- Authors
- Corti, D., Langedijk, J. P. M., Hinz, A., Seaman, M. S., Vanzetta, F., Fernandez-Rodriguez, B. M., Silacci, C., Pinna, D., Jarrossay, D., Balla-Jhagjhoorsingh, S., Willems, B., Zekveld, M. J., Dreja, H., O'Sullivan, E., Pade, C., Orkin, C., Jeffs, S. A., Montefiori, D. C., Davis, D., Weissenhorn, W., McKnight, Á., Heeney, J. L., Sallusto, F., Sattentau, Q. J., Weiss, R. A., & Lanzavecchia, A.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-01-20
- Volume
- 5
- Issue
- 1
- Pages
- e8805
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2009151161
- Cited by
- 426
- References
- 64
- FWCI
- 21.99
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.